ClinicalTrials.gg

Alcoholism clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 1,676 studies for Alcoholism across more than 10 countries. 331 are recruiting or about to start. 1,296 of them are mainly about Alcoholism (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-16.

ClinicalTrials.gov finds 1,699 studies for Alcoholism. How that becomes 1,676 here

This page counts the studies the registry files under Alcoholism, and those it files under no condition that list Alcoholismthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 16, 2026. How condition pages count

  1. 1,699Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −3List Alcoholism as a condition, but the registry did not file them under itMost often written as “Concurrent Alcohol Dependence and Pathological Gambling” (1), “Family History of Alcoholism” (1), and “Effects of Family History of Alcoholism and Sex on Alcohol Analgesia” (1). The registry filed them under other conditions only, most often Gambling (1) and Schizophrenia (1).
  3. −20Match it another way17 name it in the title, 2 in a keyword, and 1 by a synonym or other text the search reads.
  4. 1,676The count on this page2 of them list Alcoholism in their own words; the registry filed them under no condition.

Status

Completed
1,030
Recruiting
237
Status unknown
104
Terminated
85
Not yet recruiting
80
Active, not recruiting
62

Phase

Phase 2
385
Phase 1
135
Phase 3
125
Phase 4
125
Early Phase 1
32

Where

United States
1,073
France
94
Germany
66
Canada
40
United Kingdom
33
Denmark
29

Who develops what

Add Alcoholism to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 8 programs from 7 companies, 7 with this as their studies’ main aim; 2 with a live phase 3 study; 2 primary completions in the next 12 months. Compare Eli Lilly and Regeneron Pharmaceuticals here →

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

None given by two companies or more yet.

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

In phase 3Company
NaltrexonePhase 4 trial recorded☆ Track1 live phase-3 study: NCT07433413Shenzhen Sciencare Medical Industries Co., Ltd.
brenipatide☆ Track2 live phase-3 studies: NCT07219953, NCT07219966Eli Lilly and Company

The 2 in phase 3 with the nearest primary completion, of 8 programs — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (2)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

  • 1 Apr 2027 est.Naltrexone · Shenzhen Sciencare Medical Industries Co., Ltd. · Phase 3 main aimNCT07433413 Evaluate the Efficacy and Safety of Naltrexone Hydrochloride Implant in Patients With Alcohol Use Disorder — primary endpoint: Proportion of Heavy Drinking Days During the 24-Week Observation Period Post-Randomization/Post-Dosing · 240 enrolled
  • 1 Jun 2027 est.AFA-281 · Afasci Inc · Phase 2 main aimNCT06710431 A Study of the Safety and Exploratory Efficacy of Oral AFA-281 in Patients with Alcohol Use Disorder — primary endpoint: Cue-induced alcohol craving · 36 enrolled

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in Alcoholism studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here GLP-1 receptor agonists 11 open · Psychedelics 10 open · Serotonin receptor agonists 9 open · Opioid antagonists 5 open · Anxiolytics 1 open

Coming up

126studies finish main data collection within a year7 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 237 Alcoholism studies recruiting now, 84 (35%) set no upper age limit and 131 (55%) stop at 75 or younger. 9 (4%) take children under 18. 3 (1%) are for women only and 6 (3%) for men only; 64 (27%) take healthy volunteers.

Recruiting studies that take each age, of 237
AgeWomenMen
103 (1%)3 (1%)
18164 (69%)167 (70%)
30216 (91%)219 (92%)
40213 (90%)216 (91%)
50214 (90%)217 (92%)
65184 (78%)186 (78%)
75112 (47%)113 (48%)
8595 (40%)96 (41%)

Across all 1,676 studies, recruiting or not: 61% stop at 75 or younger and 50% at 65; 7% take children; 2% are for women only and 4% for men only; 27% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Alcoholism studies take

Of 134 phase 2 interventional studies under Alcoholism, half reached primary completion within 33 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 128 mo19–48 · 75 studies—34 mo21–49 · 63 studies
Phase 1/232 mo27–76 · 22 studies——
Phase 233 mo21–59 · 134 studies—35 mo23–59 · 122 studies
Phase 336 mo17–54 · 25 studies——
Phase 458 mo49–83 · 24 studies——
Interventional, no phase33 mo17–52 · 493 studies—35 mo18–54 · 470 studies
Observational40 mo21–59 · 76 studies—45 mo21–65 · 74 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 18, 2026.

Stopped2

Studies

Recruiting first, then most recently updated. Showing 50 of 1,676. Browse all 1,676 → or search them.